Stock listing

A1W96L Stock Price, News, Filings & Events — Xencor, Inc.

Selected listing: A1W96L · LSX · EUR · DE

The selected listing A1W96L:LSX represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Xencor is actively engaged in clinical trials and has announced recent updates regarding its pipeline and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to the company's progress in the biopharmaceutical sector. The market context reflects ongoing interest in innovative therapies and the competitive landscape in which Xencor operates.

A1W96L:LSXEURDEUpdated July 21, 2026
Xencor, Inc. logo
Ticker
A1W96L:LSX
Asset type
Stock
Market cap
$1.30B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Xencor, Inc. A1W96L:LSX stock context

The selected listing A1W96L:LSX represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Xencor is actively engaged in clinical trials and has announced recent updates regarding its pipeline and partnerships. Investors can find the latest news, regulatory filings, and upcoming events related to the company's progress in the biopharmaceutical sector. The market context reflects ongoing interest in innovative therapies and the competitive landscape in which Xencor operates.

Research Xencor, Inc.

Alternate listings